Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 5 results:
Author Title Type [ Year(Asc)]
Filters: Author is Voorham, J.  [Clear All Filters]
2020
M. Kerkhof, Voorham, J., Dorinsky, P., Cabrera, C., Darken, P., Kocks, J. W., Sadatsafavi, M., Sin, D. D., Carter, V., and Price, D. B., “Association between COPD exacerbations and lung function decline during maintenance therapy”, Thorax, 2020.
2019
J. Voorham, Xu, X., Price, D. B., Golam, S., Davis, J., J. Ling, Z. Jie, Kerkhof, M., Ow, M., and Tran, T. N., “Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma”, Allergy, vol. 74, pp. 273-283, 2019.
2018
D. B. Price, Trudo, F., Voorham, J., Xu, X., Kerkhof, M., J. Jie, L. Zhi, and Tran, T. N., “Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study”, J Asthma Allergy, vol. 11, pp. 193-204, 2018.
J. Voorham, Roche, N., Benhaddi, H., van der Tol, M., Carter, V., van Boven, J. F. M., Bjermer, L., Miravitlles, M., and Price, D. B., “Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK”, BMJ Open, vol. 8, p. e022051, 2018.
2017
J. van Boven, Benhaddi, H., Roche, N., Bjermer, L., Miravitlles, M., Voorham, J., and Price, D., “Real-world cost effectiveness comparison of symbicort turbuhaler and duoresp spiromax in UK patients with asthma or chronic obstructive pulmonary disease”, Value in Health, vol. 20, p. A645, 2017.
[Page last reviewed 6 April 2021]